Mississippi law funds medical center operations and research

The law provides $190,004,192 from the State General Fund and authorizes spending up to $2,232,723,926 from patient fees and other special sources for the medical center. The funding supports the University of Mississippi Medical Center, including its schools, teaching hospital, and service area. Special-source funds may be spent as they are collected or otherwise become available. The center must maintain its listed schools, teaching hospital, and service area, and report spending for each division to the Legislature at the start of its session. The funding covers July 1, 2026, through June 30, 2027.

The law provides funds for an equivalent $2,000 salary increase for professors and adjunct professors, and for repairs and upgrades to the medical center's grounds and infrastructure. The salary allocation covers professors and adjunct professors at the University of Mississippi Medical Center. The Vice Chancellor for Health Affairs decides whether to provide the salary increase. The salary funds come from the Education Enhancement Fund; the grounds and infrastructure funds come from that fund as allocated by the Treasurer's Office. These allocations cover the 2027 fiscal year, from July 1, 2026, through June 30, 2027.

The law provides $5 million to the medical center for research under the Ibogaine Drug Development Clinical Trial Act. The funds are for the University of Mississippi Medical Center to conduct research under the Ibogaine Drug Development Clinical Trial Act. A designated recipient must certify in writing and under oath that it has not made a compensation contract tied to the success or failure of legislation or executive action prohibited by state law. Funds cannot be given to or used by a recipient that does not certify or is found to have violated its certification. The act takes effect July 1, 2026.